Drug Shortage Report for TEVA-VALGANCICLOVIR
Report ID | 153189 |
Drug Identification Number | 02413825 |
Brand name | TEVA-VALGANCICLOVIR |
Common or Proper name | VALGANCICLOVIR HCL 450MG TABS |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | VALGANCICLOVIR |
Strength(s) | 450MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 60 |
ATC code | J05AB |
ATC description | DIRECT ACTING ANTIVIRALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-01-19 |
Estimated end date | 2022-04-10 |
Actual end date | 2022-06-15 |
Shortage status | Resolved |
Updated date | 2022-06-16 |
Company comments | Tranistioned/discontinued |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2022-06-16 | French | Compare |
v7 | 2022-06-16 | English | Compare |
v6 | 2022-03-25 | French | Compare |
v5 | 2022-03-25 | English | Compare |
v4 | 2022-03-17 | French | Compare |
v3 | 2022-03-17 | English | Compare |
v2 | 2022-01-20 | French | Compare |
v1 | 2022-01-20 | English | Compare |
Showing 1 to 8 of 8